Literature DB >> 24573354

MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.

Haibing Xiao1, Heng Li1, Gan Yu1, Wei Xiao2, Junhui Hu1, Kun Tang1, Jin Zeng1, Wei He1, Guohua Zeng3, Zhangqun Ye1, Hua Xu1.   

Abstract

The present study was performed to investigate the effect of microRNA-10b (miR-10b) on cell migration and invasion in human bladder cancer (BC). Real-time PCR was performed to detect the expression of miR-10b in BC cell lines. miR-10b mimics, the negative control for mimics, miR-10b inhibitor and the negative control for inhibitor were transfected into BC cell lines and the effects of miR-10b on the migration and invasion of cells were investigated through Transwell assay. Meanwhile, protein levels of KLF4, HOXD10, E-cadherin and MMP14 were measured. Luciferase assays were also performed to validate KLF4 and HOXD10 as miR-10b targets. In vivo metastasis assay was performed to validate if miR-10b can promote BC cell line metastasis in vivo. miR-10b is significantly upregulated in BC cell lines and metastatic tissues. Increased miR-10b expression significantly enhanced BC cell migration and invasion, while decreased miR-10b expression reduced cell migration and invasion. In vivo metastasis assay demonstrated that overexpression of miR-10b markedly promoted BC metastasis. Moreover, KLF4 and HOXD10 were identified as direct targets of miR-10b in BC cells. Silencing of KLF4 or HOXD10 recapitulated the pro-metastatic function. Furthermore, we found that E-cadherin and MMP14 may be the downstream factors of KLF4 and HOXD10 in the suppression of BC metastasis by miR-10b. These data suggest that miR-10b may function as oncogenes in BC cells. Targeting these novel strategies, inhibition of miR-10b/KLF4/E-cadherin axis and miR-10b/HOXD10/MMP14 axis may be helpful as a therapeutic approach to block BC cell metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24573354     DOI: 10.3892/or.2014.3048

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  49 in total

Review 1.  The fundamental role of miR-10b in metastatic cancer.

Authors:  Patrick Sheedy; Zdravka Medarova
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

Review 2.  Cell-free microRNAs in blood and other body fluids, as cancer biomarkers.

Authors:  Blanca Ortiz-Quintero
Journal:  Cell Prolif       Date:  2016-06       Impact factor: 6.831

3.  Canine urothelial carcinoma: genomically aberrant and comparatively relevant.

Authors:  S G Shapiro; S Raghunath; C Williams; A A Motsinger-Reif; J M Cullen; T Liu; D Albertson; M Ruvolo; A Bergstrom Lucas; J Jin; D W Knapp; J D Schiffman; M Breen
Journal:  Chromosome Res       Date:  2015-03-18       Impact factor: 5.239

4.  MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor.

Authors:  Ren Hou; Daixian Wang; Jian Lu
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

5.  Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.

Authors:  Jongchan Kim; Ashley N Siverly; Dahu Chen; Min Wang; Yuan Yuan; Yumeng Wang; Hyemin Lee; Jinsong Zhang; William J Muller; Han Liang; Boyi Gan; Xianbin Yang; Yutong Sun; M James You; Li Ma
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

6.  Demethylation of miR-10b plays a suppressive role in ccRCC cells.

Authors:  Cheng He; Xiaokun Zhao; Hongyi Jiang; Zhaohui Zhong; Ran Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection.

Authors:  Hai V Nguyen; Jesse Gore; Xin Zhong; Sudha S Savant; Samantha Deitz-McElyea; C Max Schmidt; Michael G House; Murray Korc
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

8.  MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells.

Authors:  Pei Zhang; Haiyu Hong; Xiaojin Sun; Hao Jiang; Shiyin Ma; Surong Zhao; Mengxiao Zhang; Zhiwei Wang; Chenchen Jiang; Hao Liu
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

9.  MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin.

Authors:  J Zhang; L Xu; Z Yang; H Lu; D Hu; W Li; Z Zhang; B Liu; S Ma
Journal:  Clin Transl Oncol       Date:  2014-09-12       Impact factor: 3.405

10.  Propofol exhibits a tumor-suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA-10b/HOXD10 signaling pathway.

Authors:  Zongcai Qi; Lei Yuan; Nenghong Sun
Journal:  Oncol Lett       Date:  2019-10-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.